Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
ITOSiTeos Therapeutics | $568.21m | n/a | n/a |
ALECAlector | $561.92m | n/a | n/a |
TERNTerns Pharmaceuticals | $548.79m | n/a | n/a |
NGNENeurogene | $548.55m | n/a | n/a |
OABIOmniAB | $548.09m | n/a | n/a |
LENZLenz Therapeutics | $547.71m | n/a | n/a |
OCSOculis Holding AG | $544.32m | n/a | n/a |
MREOMereo BioPharma | $544.14m | n/a | n/a |
PEPGPepGen | $536.50m | n/a | n/a |
CTNMContineum Therapeutics | $518.32m | 26.47 | n/a |
GRALGrail | $514.79m | n/a | n/a |
YMABY-mAbs Therapeutics | $508.60m | n/a | n/a |
FULCFulcrum Therapeutics | $497.23m | n/a | n/a |
HARPHarpoon Therapeutics | $492.35m | n/a | n/a |
HRTXHeron Therapeutics | $489.62m | n/a | n/a |
ELYMEliem Therapeutics | $487.53m | n/a | n/a |
FATEFate Therapeutics | $486.06m | n/a | n/a |
THRDThird Harmonic Bio | $483.61m | n/a | n/a |
SAVACassava Sciences | $483.60m | n/a | n/a |
NWBONorthwest Biotherapeutics | $469.22m | n/a | n/a |